ARCHIVES

Interferon Alpha-2B Effective For Malignant Melanoma

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

In Brief: Murphy New ACS President, Robert McKenna Named President Elect Gehan Receives Gottlief Award

November 18, 1983

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010